(Q29547856)

English

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins

scientific article (publication date: 8 October 2005)

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

0 references

1 reference

based on heuristic

inferred from title

Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

0 references

author name string

Baigent C

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Keech A

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Kearney PM

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Blackwell L

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Buck G

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Pollicino C

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Kirby A

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Sourjina T

8

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Peto R

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Collins R

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Simes R

11

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

publication date

8 October 2005

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

366

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

9493

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

1267-78

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The value of lowering cholesterol after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Might treatment of hypercholesterolaemia increase non-cardiac mortality?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Should there be a moratorium on the use of cholesterol lowering drugs?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing possible hazards of reducing serum cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Report of the Conference on Low Blood Cholesterol: Mortality Associations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens. Cholesterol Treatment Trialists' (CTT) Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment goals for low-density lipoprotein cholesterol in the secondary prevention of coronary heart disease: absolute levels or extent of lowering?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The association between cholesterol and death from injury

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Low serum cholesterol and the risk of cancer: an analysis of the published prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins and the risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins and prostate cancer risk: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Statin-associated myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The liver and lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2967394-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(05)67394-1

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

PubMed publication ID

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=16214597

23 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29547856&oldid=1397959645"